601Indexed trials
canonical disease area
ADHD
Intelligence
ADHD intelligence: 601 indexed trials, 66 recruiting studies, 334 sponsors across 43 countries.
66Recruiting
334Sponsors
43Countries
Leading sponsors
Massachusetts General Hospital222 recruiting
Shire170 recruiting
National Taiwan University Hospital110 recruiting
Eli Lilly and Company110 recruiting
Children's Hospital Medical Center, Cincinnati100 recruiting
Supernus Pharmaceuticals, Inc.101 recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.91 recruiting
Duke University91 recruiting
National Institute of Mental Health (NIMH)91 recruiting
Karolinska Institutet80 recruiting
Florida International University81 recruiting
Hospital de Clinicas de Porto Alegre60 recruiting
Geographic activity
United States262trials
Israel37trials
France27trials
Taiwan25trials
China24trials
Canada23trials
United Kingdom19trials
Sweden15trials
Spain14trials
Germany14trials
Turkey (Türkiye)14trials
Brazil12trials
Leading interventions
Methylphenidate24trials
Atomoxetine14trials
Behavioral Parent Training6trials
Lisdexamfetamine6trials
Atomoxetine Hydrochloride5trials
Treatment as usual5trials
atomoxetine4trials
methylphenidate4trials
Methylphenidate Transdermal System4trials
Concerta4trials
Centanafadine4trials
400mg SPN-8123trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.